News 21.03.22

Caffeine citrate is now available in Russia

Mirpharm has registered Caffeine Citrate (INN) for the treatment of primary apnea (breathing arrest) in preterm infants.

Moscow, March 2022

 

Caffeine citrate (INN), actively used by neonatologists all over the world, has become available to Russian doctors.

Launched by Mirpharm, Caffeine Citrate is specifically designed for neonatologists to combat apnea of ​​prematurity. The drug is known in the world, but for the first time presented in Russia.

Its use allows for a much earlier cessation of assisted ventilation, a reduction in the incidence of BPD, and a significant improvement in survival without neurodevelopmental impairment.


Mirpharm is an international group of companies with its own R&D centers and production facilities in Russia and the European Union.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.